China Healthwise Holdings Limited (0348.HK)
HKD 0.1
(6.45%)
HKD 0.1
(6.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 82 Thousand | -28.33 Million | 42.08 Million | 11.99 Million | 7.17 Million | -227.44 Million |
| Net Income | -134.55 Million | -56.4 Million | -100.58 Million | -26.88 Million | -156.91 Million | -106.37 Million |
| Depreciation & Amortization | 5.61 Million | 3.3 Million | 4.19 Million | 10.58 Million | 13.08 Million | 4.15 Million |
| Deferred income taxes | - | - | - | - | 40 Million | 20.63 Million |
| Stock-based compensation | - | - | - | - | 15.74 Million | 15.74 Million |
| Change in working capital | 7.1 Million | -20.65 Million | 11.34 Million | -25.18 Million | 21.35 Million | -172.6 Million |
| Other non-cash items | 126.04 Million | 45.41 Million | 127.11 Million | 53.47 Million | 73.89 Million | 11 Million |
| Investing Cash Flow | -191 Thousand | -631 Thousand | -360 Thousand | 1.49 Million | -4.63 Million | -9.47 Million |
| Investments in PPE | -191 Thousand | -631 Thousand | -360 Thousand | -4.51 Million | -3.27 Million | -7.11 Million |
| Acquisitions | - | - | - | -2.17 Million | -1.36 Million | -2.86 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 8.19 Million | -12.74 Million | 494 Thousand |
| Financing Cash Flow | -9.17 Million | 5.95 Million | -36.36 Million | -25.74 Million | -31.28 Million | 231.26 Million |
| Debt repayment | -2.54 Million | -19.22 Million | -21.16 Million | -34.5 Million | -6.89 Million | -41.28 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -4.28 Million | -28.92 Million | - |
| Common Stock Issuance | - | - | - | - | - | 150.73 Million |
| Other Financing Activities | -10.4 Million | 25.18 Million | -15.2 Million | 13.03 Million | -100.69 Million | 121.81 Million |
| Accounts receivables | 10.48 Million | -23.14 Million | -16.33 Million | -87.69 Million | 8.23 Million | - |
| Accounts payables | -2.47 Million | 10.23 Million | 7.33 Million | 62.99 Million | 71.19 Million | - |
| Inventory | -902 Thousand | 5.59 Million | -12.74 Million | -487 Thousand | 2.5 Million | -2.8 Million |
| Other working capital | 9.48 Million | -13.33 Million | 33.09 Million | -7.94 Million | -60.57 Million | -169.8 Million |
| Cash at beginning of period | 16.85 Million | 40 Million | 34.82 Million | 47.07 Million | 58.35 Million | 57.85 Million |
| Cash at end of period | 14.42 Million | 16.85 Million | 40 Million | 34.82 Million | 55.26 Million | 54.94 Million |
| Capital Expenditure | -191 Thousand | -631 Thousand | -360 Thousand | -4.51 Million | -3.27 Million | -7.11 Million |
| Effect of forex changes on cash | 307 Thousand | -141 Thousand | -181 Thousand | 20 Thousand | -3.03 Million | 2.74 Million |
| Net cash flow / Change in cash | -2.42 Million | -23.15 Million | 5.17 Million | -12.24 Million | -3.08 Million | -2.91 Million |
| Free Cash Flow | -109 Thousand | -28.97 Million | 41.72 Million | 7.47 Million | 3.9 Million | -234.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.33 Million | -14.33 Million | -51.34 Million | -134.55 Million | -51.34 Million | -31.86 Million |
| Depreciation & Amortization | 1.77 Million | 1.77 Million | 1.46 Million | 5.61 Million | 1.46 Million | 2.67 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 4.78 Million | 7.1 Million | 4.78 Million | - |
| Other non-cash items | 11.28 Million | 11.28 Million | 52.18 Million | 126.04 Million | 52.18 Million | 34.84 Million |
| Investing Cash Flow | -70.5 Thousand | -70.5 Thousand | -92.5 Thousand | -191 Thousand | -92.5 Thousand | -6000.00 |
| Investments in PPE | -70.5 Thousand | -70.5 Thousand | -91 Thousand | -191 Thousand | -91 Thousand | -4500.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -1500.00 | - | -1500.00 | 1500.00 |
| Financing Cash Flow | -2.36 Million | -2.36 Million | -4.21 Million | -9.17 Million | -4.21 Million | -8.6 Million |
| Debt repayment | - | - | - | -2.54 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.36 Million | -2.36 Million | -4.21 Million | -10.4 Million | -4.21 Million | -4.3 Million |
| Accounts receivables | - | - | 497 Thousand | 10.48 Million | 497 Thousand | - |
| Accounts payables | - | - | - | -2.47 Million | - | - |
| Inventory | - | - | -451 Thousand | -902 Thousand | -451 Thousand | - |
| Other working capital | - | - | 4.74 Million | 9.48 Million | 4.74 Million | - |
| Cash at beginning of period | - | - | 8.84 Million | 16.85 Million | - | 16.85 Million |
| Cash at end of period | -3.7 Million | -3.7 Million | 14.42 Million | 14.42 Million | 2.78 Million | 8.84 Million |
| Capital Expenditure | -70.5 Thousand | -70.5 Thousand | -91 Thousand | -191 Thousand | -91 Thousand | -4500.00 |
| Effect of forex changes on cash | 1500.00 | 1500.00 | 2000.00 | 307 Thousand | 2000.00 | 151.5 Thousand |
| Net cash flow / Change in cash | -3.7 Million | -3.7 Million | 5.57 Million | -2.42 Million | 2.78 Million | -8 Million |
| Free Cash Flow | -1.34 Million | -1.34 Million | 7 Million | -109 Thousand | 7 Million | 299.5 Thousand |
SUDARSCHEM
600516
CLS-B
KWHIF
IGPK
22UA